SCHEMBL19401565

SCHEMBL19401565

CCCNC(=O)CCC(=O)NCC

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
MCL1 Q07820 2/20 0.50
CASP2 P42575 1/20 0.50
CNR1 P21554 1/20 0.47
NAAA Q02083 1/20 0.47
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP9 P14780 1/20 0.43
DNM1 Q05193 2/20 0.42
KMT2A Q03164 3/20 0.42
MEN1 O00255 1/20 0.42
CTSD P07339 1/20 0.42
GAA P10253 1/20 0.42
ALDH1A1 P00352 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3351989 0.92 CASP2 (0.56) FAAHMCL1CASP2CNR1NAAA
SCHEMBL19703760 0.91 FAAH (0.65) FAAHMCL1CASP2CNR1NAAA
SCHEMBL28327787 0.89 FAAH (0.76) FAAHCASP2CNR1NAAADNM1
SCHEMBL5909462 0.87 FAAH (0.64) FAAHMCL1CASP2NAAAMMP1
Hexadecanoic Acid Propylamide SCHEMBL16393833 0.85 FAAH (0.84) FAAHCASP2CNR1NAAADNM1
SCHEMBL840681 0.84
SCHEMBL10124173 0.83 PHF8 (0.52) FAAHMCL1CASP2CNR1NAAA
SCHEMBL9921404 0.83 CASP2 (0.48) FAAHMCL1CASP2CNR1NAAA
SCHEMBL17860105 0.83 KMT2A (0.58) FAAHMCL1CASP2NAAAKMT2A
SCHEMBL17740222 0.83 CASP2 (0.48) FAAHMCL1CASP2CNR1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-B1 PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma AG (DE) 2022-02-23 EP disclosed
WO-2017162663-A1 PRODRUGS OF CYTOTOXIC ACTIVE AGENTS HAVING ENZYMATICALLY CLEAVABLE GROUPS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-09-28 WO disclosed